Ebola Check: Delivering molecular diagnostics at the point of need

Research output: Contribution to conferencePaperpeer-review

Abstract

The 2013-5 global outbreak of Ebolavirus disease brought to sharp focus the need for diagnostic capacity to be equitably available on a global scale: from the most under-developed areas of resource-limited countries in West Africa to high volume international travel hubs in Europe and the USA. Quick detection of the causal agent of disease is pivotal to containment, contact tracing and clinical action to protect healthcare workers, communities and patients. Nucleic acid testing (NAT) by real time reverse transcription quantitative polymerase chain reaction (RT-PCR) has emerged as the preferred method for reliable patient status confirmation. Presently, this is served through advanced clinical molecular laboratory testing in a
Original languageEnglish
Publication statusE-pub ahead of print - 12 Dec 2015
Event3rd International Medical Olympaid - Thessaloniki
Duration: 12 Dec 2015 → …

Conference

Conference3rd International Medical Olympaid
Period12/12/15 → …

Fingerprint Dive into the research topics of 'Ebola Check: Delivering molecular diagnostics at the point of need'. Together they form a unique fingerprint.

Cite this